Back to today’s briefing

Story perspectives

Nicotinamide Cuts Skin Cancer Recurrence by 14%

10/7/2025

33 2

Summary

Story summary

A study of over 33,000 survivors finds nicotinamide reduces recurrence by 14%.
Those starting after their first diagnosis see a 54% reduction.
The benefit declines with multiple prior skin cancers.
The study centers on cutaneous squamous cell carcinoma, not melanoma.
In the United Kingdom, non-melanoma skin cancers total ~155,000 annually. The National Health Service (NHS) deploys AI for detection.

1 of 1

Story summary

A study of over 33,000 survivors finds nicotinamide reduces recurrence by 14%.
Those starting after their first diagnosis see a 54% reduction.
The benefit declines with multiple prior skin cancers.
The study centers on cutaneous squamous cell carcinoma, not melanoma.
In the United Kingdom, non-melanoma skin cancers total ~155,000 annually. The National Health Service (NHS) deploys AI for detection.